Heart MRI breakthrough could spot hidden risks in thousands

NCT ID NCT04444128

Recruiting now Knowledge-focused Sponsor: Johann Wolfgang Goethe University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a detailed heart MRI (called T1 mapping) can better predict who will develop heart disease, heart failure, or long COVID complications. Researchers will scan 6000 adults without known heart disease and follow them over time. The goal is to see if subtle changes in heart tissue detected by MRI can improve risk assessment beyond standard tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better early detection of heart problems and more personalized risk assessment for conditions like heart failure and long COVID.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve health, and the new MRI method may not prove more useful than existing tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endomyocardial fibrosis heart failure Inflammation long COVID-19 myocarditis vasculitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE LONG COVID SYNDROME MYOCARDIAL FIBROSIS MYOCARDITIS VASCULAR INFLAMMATION

Contacts and locations

Locations

University Hospital Frankfurt
RECRUITING

Frankfurt am Main, Hesse, Frankfurt am Main, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.